Business

Genpact Limited Announces Pricing of 4.950% Senior Notes due 2030 by Genpact UK Finco plc and Genpact USA, Inc.

Genpact Limited ("Genpact") (NYSE: G), an agentic and advanced technology solutions company recognized for its deep industry knowledge, process intelligence and last-mile expertise, today announced the pricing by its wholly owned subsidiaries, Genpact UK Finco plc ("Genpact UK") and Genpact USA, Inc. ("Genpact USA"), of their underwritten public offering (the "Notes Offering") of $350 million aggregate principal amount of 4.950% senior notes due 2030 (the "Notes"). The Notes will be senior unsec

articleTechnology Solutions CoNovember 13, 20254/company/technology-solutions-co/news/genpact-limited-announces-pricing-of-4950percent-senior-notes-due-2030-by-genpact-uk-finco-plc-and-genpact-usa-inc
Genpact Limited Announces Pricing of 4.950% Senior Notes due 2030 by Genpact UK Finco plc and Genpact USA, Inc.

About this update from Technology Solutions Co

[{"type":"text","content":"NEW YORK, Nov. 13, 2025 /PRNewswire/ -- Genpact Limited ("Genpact") (NYSE: G), an agentic and advanced technology solutions company recognized for its deep industry knowledge, process intelligence and last-mile expertise, today announced the pricing by its wholly owned subsidiaries, Genpact UK Finco plc ("Genpact UK") and Genpact USA, Inc. ("Genpact USA"), of their underwritten public offering (the "Notes Offering") of $350 million aggregate principal amount of 4.950% senior notes due 2030 (the "Notes"). The Notes will be senior unsecured obligations of Genpact UK and Genpact USA and will be guaranteed on a senior unsecured basis by Genpact and Genpact Luxembourg S.à r.l. ("Genpact Luxembourg"). Genpact expects the Notes Offering to close on November 18, 2025, subject to the satisfaction of customary closing conditions.","length":901,"tagName":"p"},{"type":"image","alt":"Genpact Logo (PRNewsfoto/Genpact)","displaySize":"","headline":null,"caption":"Genpact Logo (PRNewsfoto/Genpact)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/3c9b0a25a5ec89d3292ad041a2af7ca7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/kX24aNlv_oJEaOzaxsLsbw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/3c9b0a25a5ec89d3292ad041a2af7ca7","width":400,"height":400}},"href":"https://mma.prnewswire.com/media/2490373/Genpact_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Genpact intends to use the net proceeds from the offering for general corporate purposes, which may include repaying or redeeming Genpact Luxembourg's and Genpact USA's outstanding 1.750% senior notes due 2026 at or prior to their maturity on April 10, 2026.","length":266,"tagName":"p"},{"type":"text","content":"The Notes Offering is being made pursuant to a prospectus supplement and an accompanying prospectus filed as part of an effective shelf registration statement by Genpact, Genpact Luxembourg, Genpact UK and Genpact USA with the Securities and Exchange Commission ("SEC") on Form S-3 (File No. 333-291491). You may obtain a copy of the preliminary prospectus supplement, the accompanying prospectus, and the final prospectus supplement, wh...

More updates from Technology Solutions Co

GenpactGenpact USAGenpact Luxembourg